Fujifilm

Cameras and lenses are displayed at Fujifilm Holdings headquarters, in Tokyo, Japan June 7, 2024. REUTERS/Rocky Swift
World+Biz

Fujifilm once struggled to sell cameras. Now, it can't keep up with demand

Fujifilm is struggling to meet demand for the $1,599 camera, prized by young 20-something social media fans for its looks and high-end functions.

Tablets of Avigan are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo. REUTERS/Issei Kato
Coronavirus chronicle

Fujifilm starts new late-phase trial of Avigan in Japan for Covid-19 patients

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media
Coronavirus chronicle

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media

FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato/File Photo
Coronavirus chronicle

Fujifilm seeks approval for Avigan as Covid-19 treatment in Japan

Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. Photo: Issei Kato via Reuters
Coronavirus chronicle

Fujifilm says COVID-19 drug research may drag on into July

Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials
Global Economy

Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

Materials for a rapid test kit for coronavirus (COVID-19) are displayed at a laboratory in Ankara, Turkey, March 21, 2020, Photo: Reuters
Coronavirus chronicle

Fujifilm says new coronavirus test can produce results in two hours